ProAssurance Stockholders Approve Acquisition by The Doctors Company

ProAssurance ( (PRA) ) has issued an announcement.

On June 24, 2025, ProAssurance Corporation announced that its stockholders approved the proposed acquisition by The Doctors Company, with over 99% of shares voting in favor. The transaction, expected to close in the first half of 2026, is subject to regulatory approvals and customary conditions. Upon completion, ProAssurance will become a wholly owned subsidiary of The Doctors Company, and its stock will be delisted from the New York Stock Exchange. The merger aims to combine the strengths of both companies to better serve healthcare providers, leveraging their shared history in the medical professional liability market.

The most recent analyst rating on (PRA) stock is a Hold with a $18.00 price target. To see the full list of analyst forecasts on ProAssurance stock, see the PRA Stock Forecast page.

Spark’s Take on PRA Stock

According to Spark, TipRanks’ AI Analyst, PRA is a Neutral.

The overall stock score reflects a mixture of moderate financial performance and valuation concerns, offset by positive short-term corporate developments. Financial performance is a key strength, but cash flow issues and high valuation present ongoing risks. Technical analysis shows weak market momentum, highlighting potential short-term volatility.

To see Spark’s full report on PRA stock, click here.

More about ProAssurance

ProAssurance Corporation is a leading specialty insurer with a focus on medical professional liability and products liability for medical technology and life sciences. The company also provides workers’ compensation insurance in the eastern United States and is rated ‘A’ (Excellent) by AM Best.

Average Trading Volume: 709,017

Technical Sentiment Signal: Buy

Current Market Cap: $1.17B

See more insights into PRA stock on TipRanks’ Stock Analysis page.